Angela J. Villar

Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration

Ahmad Salehi, Jean‐Dominique Delcroix, Pavel V. Belichenko et al. · Neuron · 2006 · 547 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome

Alexander M. Kleschevnikov, Pavel V. Belichenko, Angela J. Villar et al. · Journal of Neuroscience · 2004 · 469 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome

Pavel V. Belichenko, Eliezer Masliah, Alexander M. Kleschevnikov et al. · The Journal of Comparative Neurology · 2004 · 302 citations

Life Sciences, Neurobiology, Neuroscience +17

<i>App</i>Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome

Anne M. Cataldo, Suzana Petanceska, Corrinne M. Peterhoff et al. · Journal of Neuroscience · 2003 · 246 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats.

Jason Conger, Jack D. Robinette, Angela J. Villar et al. · Journal of Clinical Investigation · 1995 · 117 citations · Full text

Medicine, Nephrology, Pharmacology +16